Search Results
36 items found for "Aaron Sato"
Posts (11)
- Newly launched antibody libraries put hard-to-drug targets within reach
Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates.
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
The "herb-component-target" network indicated that the ingredients of Girinimbin, Gomisin B and Asarone In conclusion, this study preliminarily revealed key active components in KXS, including Gomisin B, Asarone
- 📰 GPCR Weekly News, July 3 to 9, 2023
GPCRs, Ion Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs NEW Postdoctoral Fellow, Caron
Other Pages (25)
- Ep 16 with Dr. Aaron Sato
Aaron Sato About this episode In this episode of the Dr. GPCR Podcast , I spoke to Dr. Aaron Sato from Twist Biopharma , a vertical within Twist Bioscience . Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. Sato published over 30 peer-reviewed papers and contributed to 40 issued patents in the antibody space Aaron Sato on the web LinkedIn Twitter Google Scholar Twist Bioscience Twist Biopharma Dr.
- Ep 16 with Dr. Aaron Sato
Aaron Sato from Twist Biopharma , a vertical within Twist Bioscience . Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. Sato published over 30 peer-reviewed papers and contributed to 40 issued patents in the antibody space During our time together, Aaron and I discussed how using Twist Bioscience’s proprietary technology to Aaron Sato on the web LinkedIn Twitter Google Scholar Twist Bioscience Twist Biopharma Dr.
- 20-10 Dr GPCR Newsletter
Aaron Sato, CSO of Twist Biopharma, available on October 28th. Aaron Sato. Subscribe today where you listen to podcasts.